Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
27 September 2019 | Story Ruan Bruwer | Photo Tania Allen
Netball
The Kovsies will face the Maties in the semi-finals of Varsity Netball in search of their fourth appearance in a final.
On Monday (30 September), the University of the Free State (UFS) netball team will have an ideal opportunity for revenge for what happened in this year’s Varsity Cup. In the semi-finals of the Varsity Cup back in April, the Shimla rugby team received a decent hiding from the Maties.

Now the UFS and Maties will face each other in another semi-final, this time in the netball version of the Varsity Cup, called Varsity Netball. The teams square off in the Callie Human Centre at 17:00.

Since losing to Tuks in the opening round, Kovsies have built up good momentum and confidence with six consecutive victories, including one over the Stellenbosch students on Monday (23 September). The score was 65-61.

The other wins were against UJ (69-35), TUT (64-20), NWU (59-55), Madibaz (70-41), and UWC (99-18), earning them the second spot on the log behind Tuks. The 99 goals against UWC were their best ever in the competition.The Free State women also won their encounter against Maties at this year’s USSA tournament by 38-31.

A victory would earn the team a shot at another Varsity Netball title. They have never lost a final, having appeared in three previous finals (2013, 2014, and 2018). Kovsies have won three of their previous five Varsity Netball semi-finals. They had met Maties only once before in a semi-final. This was last year in Bloemfontein when Kovsies prevailed by 56-45.
Khomotso Mamburu, goal defence of Maties, and Adéle Niemand, their assistant coach, both represented the Kovsies for many years.

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.
Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept